Top Markets
#1 Akedo Akedo +146.29%
#2 TENDIES TENDIES +96.27%
#3 Threshold Network Threshold Network +47.05%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +27.69%
#6 Bitway Bitway +26.92%
#7 MultiversX MultiversX +23.94%
#8 Palladium Network Palladium Network +22.69%
#9 Cash Cat Cash Cat +22.59%
#10 aelf aelf +19.17%
Coin of the day
Akedo Akedo
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Rang in aandelen #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Aandeelprijs
$8.16
Laatst gesynchroniseerd: 2025-06-26
Marktkapitalisatie
$234.57M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Regulus Therapeutics Inc. (RGLS)

Categorie

Healthcare
EPS voor Regulus Therapeutics Inc. (RGLS)
EPS per March 2025 TTM: $-0.73
Volgens de laatste financiële rapporten en de aandelenkoers van Regulus Therapeutics Inc. is de huidige EPS van het bedrijf (TTM) $-0.73. Eind 2023 had het bedrijf een EPS van $-1.58, een daling ten opzichte van de EPS van 2022 die $-1.86 bedroeg.
EPS-geschiedenis van Regulus Therapeutics Inc. van 2010 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.73 -10.98%
2024 $-0.82 -48.10%
2023 $-1.58 -15.05%
2022 $-1.86 -42.59%
2021 $-3.24 -28.00%
2020 $-4.50 -58.22%
2019 $-10.77 -80.72%
2018 $-55.87 -32.67%
2017 $-82.98 -55.37%
2016 $-185.94 42.90%
2015 $-130.12 -15.65%
2014 $-154.27 164.98%
2013 $-58.22 -77.11%
2012 $-254.37 -92.84%
2011 $-3.55K -51.14%
2010 $-7.27K 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,472.60%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -3,900.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 993.15%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 624.66%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH